Related Experiment Video
Updated: Jun 2, 2026
08:45
Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
Published on: May 10, 2022
Genome-wide association study identifies genetic loci associated with iron deficiency
Christine E McLaren1, Chad P Garner, Clare C Constantine
1Department of Epidemiology, University of California Irvine, Irvine, California, United States of America. cmclaren@uci.edu
Plos One
|April 13, 2011
Summary
This study identified genetic factors influencing iron deficiency through a genome-wide association study. Key single nucleotide polymorphisms (SNPs) were found, including a known transferrin gene variant and a potential new locus, advancing our understanding of iron metabolism genetics.
Area of Science:
- Genetics
- Human Metabolism
- Molecular Biology
Background:
- Inherited disorders highlight genetic influences on iron metabolism.
- Iron deficiency has complex genetic underpinnings.
- Understanding genetic loci for iron deficiency is crucial for public health.
Purpose of the Study:
- To identify novel genomic locations associated with iron deficiency.
- To investigate the genetic basis of iron status variations.
- To validate findings through replication studies.
Main Methods:
- Genome-wide association study (GWAS) on a cohort with defined iron deficiency criteria.
- Analysis of 331,060 single nucleotide polymorphisms (SNPs) in relation to serum iron measures.
- Replication analysis in an independent cohort of US veterans.
Main Results:
- Five significant SNPs associated with iron status were identified, including rs3811647 in the transferrin (TF) gene and rs1800562 (C282Y mutation) in the HFE gene.
- Replication confirmed the association of rs3811647 with total iron binding capacity and HFE C282Y mutations.
- A novel SNP, rs2698530 on chromosome 2p14, showed strong association with iron status outcomes.
Conclusions:
- The study confirms a known transferrin gene polymorphism's role in iron status.
- A potential new genetic locus (rs2698530) implicated in iron deficiency warrants further investigation.
- These findings contribute to understanding the genetic architecture of iron metabolism.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...